Nivolumab with chemotherapy shows significant event-free survival improvement in resectable NSCLC, reducing recurrence risk post-surgery.
Kristi Rosa is the Managing Editor for OncLive, a leading source of news, analysis, and clinical information for oncology professionals. With a focus on cancer research and treatment, Kristi's articles cover a wide range of topics, including clinical trial updates, drug approvals, and advancements in cancer care. Her work has been featured in various publications, including AJMC - The American Journal of Managed Care, Oncology Nursing News, and Contagion_Live.